Stock Events

Stock Events

Gossamer Bio 

$10.96
116
-$0.56-4.86% 08:00 Today

Statistics

Day High
11.66
Day Low
11.46
52W High
309.6
52W Low
9.12
Volume
21,728
Avg. Volume
-
Mkt Cap
70.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-9.87
-6.63
-3.39
-0.15
Expected EPS
-3.791429
Actual EPS
N/A

Financials

-351.49%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
48.47MRevenue
-170.37MNet Income

Analyst Ratings

$30.43Average Price Target
The highest estimate is 90.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
0%
Sell
33%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GOSS. It's not an investment recommendation.
NVIDIA
18
NVDA
Tesla
16
TSLA
Microsoft
15
MSFT
Realty Income
15
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap133.37B
Vertex Pharmaceuticals is a competitor because it also focuses on developing treatments for serious genetic diseases, similar to Gossamer Bio's focus on immunology and oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.13B
Regeneron Pharmaceuticals competes in the biotech space with a strong emphasis on immunology and inflammatory conditions, overlapping with Gossamer Bio's research areas.
Gilead Sciences
GILD
Mkt Cap187.15B
Gilead Sciences is a direct competitor in the biopharmaceutical field, particularly in areas like immunology and viral diseases, which are of interest to Gossamer Bio.
AMGEN
AMGN
Mkt Cap224.15B
Amgen competes with Gossamer Bio in the biotech industry, focusing on innovative therapeutics in areas such as oncology and cardiovascular disease.
Biogen
BIIB
Mkt Cap33.63B
Biogen is a competitor due to its focus on developing therapies for neurological and neurodegenerative diseases, a field that intersects with Gossamer Bio's interest in complex diseases.
Abbvie
ABBV
Mkt Cap467.12B
AbbVie competes in the pharmaceutical and biotech sectors with a strong portfolio in immunology, oncology, and virology, areas Gossamer Bio is involved in.
Merck
MRK
Mkt Cap367.07B
Merck & Co. is a competitor because of its extensive research and development in pharmaceuticals, including immunotherapy treatments that could compete with Gossamer Bio's products.
Pfizer
PFE
Mkt Cap163.41B
Pfizer is a global pharmaceutical company with a broad range of products that compete across several of Gossamer Bio's key areas of interest, including immunology and oncology.
Novartis
NVS
Mkt Cap276.48B
Novartis competes with Gossamer Bio in the pharmaceutical sector, particularly in research and development of innovative medicines in areas like autoimmunity, which overlaps with Gossamer's focus.
Astrazeneca
AZN
Mkt Cap258.35B
AstraZeneca is a competitor because of its strong emphasis on the development of medicines in oncology, cardiovascular, renal, metabolism, and respiratory diseases, competing with Gossamer Bio's therapeutic areas.

About

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Show more...
CEO
Faheem Hasnain
Employees
162
Country
United States
ISIN
US38341P2011
WKN
000A42M0V

Listings

MU
DE
4GB.MU
XNAS
US
GOSS
BOATS
BOATS
GOSS.BOATS
F
DE
4GB0.F

0 Comments

Share your thoughts

FAQ

What is Gossamer Bio stock price today?▼
The current price of GOSS is $10.96 USD — it has decreased by -4.86% in the past 24 hours. Watch Gossamer Bio stock price performance more closely on the chart.
What is Gossamer Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Gossamer Bio stocks are traded under the ticker GOSS.
Is Gossamer Bio stock price growing?▼
GOSS stock has fallen by -1.45% compared to the previous week, the month change is a -15.29% fall, over the last year Gossamer Bio has showed a -94.89% decrease.
What is Gossamer Bio market cap?▼
Today Gossamer Bio has the market capitalization of 70.46M
When is the next Gossamer Bio earnings date?▼
Gossamer Bio is going to release the next earnings report on November 05, 2026.
What were Gossamer Bio earnings last quarter?▼
GOSS earnings for the last quarter are -6.4 USD per share, whereas the estimation was -9.87 USD resulting in a +35.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Gossamer Bio revenue for the last year?▼
Gossamer Bio revenue for the last year amounts to 48.47M USD.
What is Gossamer Bio net income for the last year?▼
GOSS net income for the last year is -170.37M USD.
How many employees does Gossamer Bio have?▼
As of September 29, 2026, the company has 162 employees.
In which sector is Gossamer Bio located?▼
Gossamer Bio operates in the Health & Wellness sector.
When did Gossamer Bio complete a stock split?▼
The last stock split for Gossamer Bio was on September 11, 2026 with a ratio of 1:80.
Where is Gossamer Bio headquartered?▼
Gossamer Bio is headquartered in SAN DIEGO, United States.